A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

NCT04294810 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

620

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Atezolizumab
DRUG: Tiragolumab
DRUG: Matching Placebo

Sponsor

Hoffmann-La Roche